Intravenous human umbilical cord-derived mesenchymal stem cell transplantation for ischemic stroke (MERIT): A phase 1 trial.

Cell Rep Med · 2026 · PMC13293954 · PMID 42208543

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Complement components (C3 and C4) and immunoglobulins (IgA, IgG, and IgM) exhibited small numerical increases, whereas C-reactive protein levels showed a decreasing trend after treatment ( Figure S8 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.